RAPT THERAPEUTICS INC has a total of 28 patent applications. It increased the IP activity by 250.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CUREGENIX INC, RECORDATI IND CHIMICA E FARMACEUTICA S P A and ADIPHARM EAD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | China | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Zibinsky Mikhail | 18 |
#2 | Okano Akinori | 16 |
#3 | Jackson Jeffrey J | 15 |
#4 | Wustrow David Juergen | 15 |
#5 | Younai Ashkaan | 14 |
#6 | Reilly Maureen Kay | 14 |
#7 | Ketcham John Michael | 14 |
#8 | Robles-Resendiz Omar | 13 |
#9 | Schwarz Jacob Bradley | 11 |
#10 | Tivitmahaisoon Parcharee | 10 |
Publication | Filing date | Title |
---|---|---|
US2020095260A1 | Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof | |
US2019375753A1 | Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses | |
KR20200125932A | Chemokine receptor modulators and uses thereof | |
AU2018360766A1 | Anticancer agents |